The Cooper Companies, Inc. (NASDAQ:COO) Receives Consensus Recommendation of “Moderate Buy” from Analysts

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned an average recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $113.61.

Several equities research analysts have weighed in on COO shares. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Piper Sandler raised their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Robert W. Baird boosted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and raised their price objective for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Finally, Wells Fargo & Company boosted their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th.

Hedge Funds Weigh In On Cooper Companies

A number of hedge funds have recently modified their holdings of COO. Treasurer of the State of North Carolina grew its position in Cooper Companies by 0.9% during the 4th quarter. Treasurer of the State of North Carolina now owns 22,861 shares of the medical device company’s stock worth $8,652,000 after purchasing an additional 212 shares during the last quarter. Hsbc Holdings PLC grew its holdings in shares of Cooper Companies by 55.3% during the fourth quarter. Hsbc Holdings PLC now owns 87,718 shares of the medical device company’s stock worth $33,188,000 after buying an additional 31,234 shares during the last quarter. Quantbot Technologies LP acquired a new position in Cooper Companies in the 1st quarter valued at about $2,211,000. Whittier Trust Co. raised its stake in Cooper Companies by 298.9% during the 1st quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock valued at $1,211,000 after acquiring an additional 8,947 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. lifted its position in Cooper Companies by 43.1% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock worth $3,076,000 after acquiring an additional 10,616 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Up 0.9 %

Shares of NASDAQ:COO opened at $106.50 on Friday. The firm’s 50-day moving average is $92.92 and its two-hundred day moving average is $94.55. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.14. Cooper Companies has a 1 year low of $75.93 and a 1 year high of $107.46. The firm has a market capitalization of $21.21 billion, a PE ratio of 62.65, a price-to-earnings-growth ratio of 2.56 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. During the same period in the prior year, the business earned $0.84 EPS. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. Analysts predict that Cooper Companies will post 3.66 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.